G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech takes a beating in market meltdown October 01, 2008 | Press Release
Biotech outperforms market in May June 02, 2008 | Press Release
Biotech Treads Water in April May 01, 2008 | Press Release
See all NewsVenture Capital
ProteoGenix, Inc. is a Portland, OR based molecular diagnostic company that is focused on maternal-fetal health. The Company has developed a robust discovery platform through integration of genomic, proteomic and bioinformatics technologies and has utilized their high-throughput protein analysis techniques to identify protein biomarkers for pregnancy related complications.
For more information, please visit
